Next-Gen Screening: First Multi-Center Pilot for Embryo "Whole Genome Sequencing" Launches in Beijing
【Abstract】: (Scientific Projection) Moving beyond panel-based PGT-A, a consortium of top Beijing reproductive centers has launched a pilot study applying Whole Genome Sequencing (WGS) to blastocysts. This technology aims to identify not just chromosomal errors but also polygenic risk scores for conditions like diabetes and heart disease.
Business Insight: While ethically debated, the commercial demand for "Perfect Baby" screening is undeniable among affluent Chinese parents. If validated, WGS could increase the revenue per IVF cycle by $2,000-$3,000. Genetic testing companies are racing to build the bioinformatics pipeline to interpret this massive amount of data for clinicians.
【Keywords】: #WGS #Genomics #FutureOfIVF
